Y. Sha et al. / Tetrahedron Letters 43 (2002) 9417–9419
9419
References
7. Selected characterization data of the third generation den-
drimers. G3-(OH)16, 6: IR 3392, 2951, 2833, 1728(s), 1624(s)
1. (a) Newkome, G. R.; Moorefield, C. N.; Vogtle, F. Dendritic
Molecules: Concepts, Synthesis, Perspectives; VCH: Wein-
heim, 1996; (b) Zeng, F.; Zimmerman, S. C. Chem. Rev.
1997, 97, 1681–1712; (c) Fischer, M.; Vogtle, F. Angew.
Chem., Int. Ed. Engl. 1999, 38, 884–905; (d) Tomalia, D. A.;
Naylor, A.; Goddard, W. A. Angew. Chem., Int. Ed. Engl.
1990, 29, 138–175; (e) Grayson, S. K.; Frechet, J. M. J.
Chem. Rev. 2001, 101, 3819–3867.
2. Astruc, D.; Chardac, F. Chem. Rev. 2001, 101, 2991–3023.
3. Hecht, S.; Frechet, J. M. J. Angew. Chem., Int. Ed. Engl.
2001, 40, 74–91.
4. Adronov, A.; Frechet, J. M. J. Chem. Commun. 2000,
1701–1710.
5. (a) Florence, A. T.; Hussain, N. Adv. Drug Deliv. Rev. 2001,
50, 69–89; (b) Twyman, L. J.; Beezer, A. E.; Esfand, R.;
Hardy, M. J.; Mitchell, J. C. Tetrahedron Lett. 1999, 40,
1743–1746; (c) Esfand, R.; Tomalia, D. A. Drug Discov.
Today 2001, 6, 427–436; (d) Malik, N.; Wiwattanapatapee,
R.; Klopsch, R.; Lorenz, K.; Frey, H.; Weener, J. W.;
Meijer, E. W.; Paulus, W.; Duncan, R. J. Controlled Release
2000, 65, 133–148; (e) Liu, M.; Frechet, J. M. J. Pharm. Sci.
Technol. Today 1999, 2, 393–401.
cm−1 1H NMR (500 MHz, CDCl3) l 4.13 (t, 24H,
;
-CO2CH2-, J=6.2 Hz), 3.78 (bs, 16H, -OH), 3.64–3.58 (m,
8H, -NCH2CH2N-, piperazine), 3.60 (t, 32H, -CH2OH,
J=5.5 Hz), 2.91–2.87 (m, 12H, OꢀCCH2CH2N-, J=
6.9 Hz), 2.84 (t, 16H, OꢀCCH2CH2N-, J=6.9 Hz), 2.78 (t,
24H, -NCH2CH2OCꢀO, J=6.2 Hz), 2.63 (t, 32H,
-NCH2CH2OH, J=5.5 Hz), 2.51 (t, 20H, OꢀCCH2-, J=6.9
Hz), 2.46 (t, 8H, OꢀCCH2-, J=6.9 Hz); 13C NMR (50 MHz,
CDCl3) l 173.06, 172.22, 62.70, 62.44, 60.49, 59.51, 59.10,
56.33, 55.82, 52.75, 50.83, 50.44, 49.81, 32.90, 32.77, 31.30;
ESI-MS: calcd for (M+H)+: 2315.7. Found: m/z (M+H)+:
2315.6. G3-(acrylate)16, 7: IR 2958, 2835, 1724(s), 1637 cm−1
;
1H NMR (500 MHz, CDCl3) l 6.40 (q, 16H, ꢀCH, J=17.5
Hz, J%=1.0 Hz), 6.12 (q, 16H, OꢀCCHꢀ, J=17.5 Hz,
J%=10.5 Hz), 5.84 (q, 16H, ꢀCH, J=10.5 Hz, J%=1.0 Hz),
4.21 (t, 32H, CH2ꢀCHCOOCH2-, J=6.0 Hz), 4.10 (t, 24H,
-COOCH2-, J=6.0 Hz), 3.65–3.49 (q, 8H, -NCH2CH2N-,
piperazine), 2.91 (m, 28H, OꢀCCH2CH2N-, J=7.0 Hz), 2.85
(m, 32H, CH2ꢀCHCOOCH2CH2N-, J=6.0 Hz), 2.77 (t,
24H, -NCH2CH2OC=O, J=6.0 Hz), 2.47 (t, 28H,
OꢀCCH2-, J=7.0 Hz); 13C NMR (50 MHz, CDCl3) l
171.87, 165.77, 130.60 (-CHꢀCH2), 128.24 (-CHꢀCH2),
62.47, 62.28, 52.53, 50.28, 32.92, 31.15, 30.14; ESI-MS: calcd
for (M+H)+: 3180.5. Found: m/z (M+H)+: 3183.0.
6. Moszner, N.; Volkel, T.; Rheinberger, V. Macromol. Chem.
Phy. 1996, 197, 621–631.